These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31076954)

  • 1. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis.
    Goldberg M; Sutradhar R; Paszat L; Whelan TJ; Gu S; Fong C; Rakovitch E
    Breast Cancer Res Treat; 2019 Aug; 176(3):657-667. PubMed ID: 31076954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery.
    Rodin D; Sutradhar R; Jerzak KJ; Hahn E; Nguyen L; Castelo M; Fatiregun O; Fong C; Mata DGMM; Trebinjac S; Paszat L; Rakovitch E
    Breast Cancer Res Treat; 2023 Aug; 201(1):77-87. PubMed ID: 37326765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer.
    Jhawar SR; Alpert N; Taioli E; Sayan M; Bazan J; Park KU; Stover D; Cherian M; White J; Haffty B; Ohri N
    Cancer Med; 2020 Nov; 9(22):8345-8354. PubMed ID: 32942344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery.
    Murphy CT; Li T; Wang LS; Obeid EI; Bleicher RJ; Eastwick G; Johnson ME; Hayes SB; Weiss SE; Anderson PR
    Clin Breast Cancer; 2015 Oct; 15(5):381-9. PubMed ID: 25861716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis.
    Thöne K; Rudolph A; Obi N; Chang-Claude J; Flesch-Janys D
    Breast Cancer Res Treat; 2018 Jul; 170(2):381-390. PubMed ID: 29556781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The time-varying effect of radiotherapy after breast-conserving surgery for DCIS.
    Rakovitch E; Sutradhar R; Hallett M; Thompson AM; Gu S; Dumeaux V; Whelan TJ; Paszat L
    Breast Cancer Res Treat; 2019 Nov; 178(1):221-230. PubMed ID: 31368035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study.
    Joseph K; Zebak S; Alba V; Mah K; Au C; Vos L; Ghosh S; Abraham A; Chafe S; Wiebe E; Liu HW; Chambers C; Gabos Z; Tankel K; Lupichuk S; King K
    Radiother Oncol; 2021 Jan; 154():93-100. PubMed ID: 32941956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).
    Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
    Breast Cancer Res Treat; 2018 Sep; 171(2):335-344. PubMed ID: 29808288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
    Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
    Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
    van Hezewijk M; Bastiaannet E; Putter H; Scholten AN; Liefers GJ; Rea D; Hasenburg A; Paridaens R; Hozumi Y; Markopoulos C; Seynaeve C; Jones SE; Marijnen CA; van de Velde CJ
    Radiother Oncol; 2013 Aug; 108(2):190-6. PubMed ID: 24044798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of patients at very low risk of local recurrence after breast-conserving surgery.
    Smith SL; Truong PT; Lu L; Lesperance M; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):556-62. PubMed ID: 24929165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade.
    Barbour S; Moore J; Dunn N; Effeney R; Harden H; McCarthy A; Walpole E; Lehman M
    Breast; 2017 Oct; 35():169-176. PubMed ID: 28756338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
    Schonberg MA; Marcantonio ER; Li D; Silliman RA; Ngo L; McCarthy EP
    J Clin Oncol; 2010 Apr; 28(12):2038-45. PubMed ID: 20308658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
    Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.
    Sagara Y; Freedman RA; Wong SM; Aydogan F; Nguyen A; Barry WT; Golshan M
    Breast Cancer Res Treat; 2017 Nov; 166(2):583-592. PubMed ID: 28776282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.
    Buszek SM; Lin HY; Bedrosian I; Tamirisa N; Babiera GV; Shen Y; Shaitelman SF
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):795-802. PubMed ID: 31377160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer.
    Abrahimi MS; Elwood M; Lawrenson R; Campbell I; Tin Tin S
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.